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Background
Cannabinoids and the endo-cannabinoid system play an
important role in the sensation of pain. As conventional
analgesics are often associated with serious side-effects,
cannabinoids and agonists of their receptors offer a use-
ful alternative or coanalgesic in the treatment of pain.
The aim of this work is to summarize the role of canna-
binoids and their receptors in nociception and pain
treatment.
Materials and methods
Two main types of receptors for cannabinoids and
endo-cannabinoids are implicated in nociception: the
metabotropic cannabinoid receptors (mainly CB1 and
CB2) and the ionotropic transient receptor potential
channels TRP, which include the vanilloid receptors
TRPV1, TRPV2, TRPV4 as well as TRPM8 and TRPA1.
Results
Antinociception related to CB1 receptor activation may
be due to inhibition of GABA release in the brain, sup-
pression of glutamate release in the spinal cord or due to
induction of dopamine, noradrenaline and opioid peptide
release. CB2 receptors are most likely implicated in anti-
nociception of tonic inflammatory pain. Cannabinoid
activation of TRP channels can result in desensitization
of the TRPA1 and TRPV1 channel activities, inhibition of
nociceptors, and antihyperalgesia and antinociception in
certain pain models. There is also evidence for coopera-
tion between metabotropic cannabinoid receptors and
ionotropic TRP channels in nociceptive neurons.
Conclusions
Cannabinoids seem to be effective against neuropathic
pain, inflammatory pain, post-operative pain and cancer
pain. Their use as analgesics or coanalgesics may offer a
useful alterative option for pain management in clinical
practice.
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